These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8356593)

  • 1. The antilymphocytic activity of brequinar sodium and its potentiation by cytidine. Effects on lymphocyte proliferation and cytokine production.
    Woo J; Lemster B; Tamura K; Starzl TE; Thomson AW
    Transplantation; 1993 Aug; 56(2):374-81. PubMed ID: 8356593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of lymphoproliferative and autoimmune disease in MRL-lpr/lpr mice by brequinar sodium: mechanisms of action.
    Xu X; Gong H; Blinder L; Shen J; Williams JW; Chong AS
    J Pharmacol Exp Ther; 1997 Nov; 283(2):869-75. PubMed ID: 9353408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo mechanisms of action of the antiproliferative and immunosuppressive agent, brequinar sodium.
    Xu X; Williams JW; Shen J; Gong H; Yin DP; Blinder L; Elder RT; Sankary H; Finnegan A; Chong AS
    J Immunol; 1998 Jan; 160(2):846-53. PubMed ID: 9551920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brequinar sodium inhibits interleukin-6-induced differentiation of a human B-cell line into IgM-secreting plasma cells.
    Tamura K; Woo J; Bakri MT; Thomson AW
    Immunology; 1993 Aug; 79(4):587-93. PubMed ID: 8406583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synergism of brequinar sodium and cyclosporine used in combination to prevent cardiac allograft rejection in the rat.
    Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L
    Transplantation; 1993 Sep; 56(3):667-72. PubMed ID: 8212165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mechanisms of brequinar sodium immunosuppression on T cell activation.
    Forrest TL; Ware RE; Howard T; Jaffee BD; Denning SM
    Transplantation; 1994 Oct; 58(8):920-6. PubMed ID: 7940736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
    Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
    Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of the antiproliferative activity of brequinar sodium for murine lymphocytes by exogenous cytidine.
    Thomson AW; Woo J; Lemster B; Todo S; Fung JJ; Starzl TE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):704-5. PubMed ID: 8438446
    [No Abstract]   [Full Text] [Related]  

  • 9. The synergistic interactions in vitro and in vivo of brequinar sodium with cyclosporine or rapamycin alone and in triple combination.
    Kahan BD; Tejpal N; Gibbons-Stubbers S; Tu Y; Wang M; Stepkowski S; Chou TC
    Transplantation; 1993 Apr; 55(4):894-900. PubMed ID: 8475566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prolongation of concordant hamster-to-rat cardiac xenografts by brequinar sodium.
    Cramer DV; Chapman FA; Jaffee BD; Zajac I; Hreha-Eiras G; Yasunaga C; Wu GD; Makowka L
    Transplantation; 1992 Sep; 54(3):403-8. PubMed ID: 1412717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of orthotopic liver allograft rejection in rats with a short-term brequinar sodium therapy. Analysis of intragraft cytokine gene expression.
    Shirwan H; Cosenza CA; Wang HK; Wu GD; Makowka L; Cramer DV
    Transplantation; 1994 Apr; 57(7):1072-80. PubMed ID: 8165706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of the novel anticancer agent 6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarbo xylic acid sodium salt (NSC 368390): inhibition of de novo pyrimidine nucleotide biosynthesis.
    Chen SF; Ruben RL; Dexter DL
    Cancer Res; 1986 Oct; 46(10):5014-9. PubMed ID: 3019518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brequinar sodium: monitoring immunosuppressive activity.
    Eiras-Hreha G; Cramer DV; Cosenza C; Chapman FA; Mills L; Cajulis E; Hill D; Jones E; Zajac I; Jaffee B
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):32-6. PubMed ID: 8516940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine mRNA expression in tolerant heart allografts after immunosuppression with cyclosporine, sirolimus or brequinar.
    Tian L; Stepkowski SM; Qu X; Wang ME; Wang M; Yu J; Kahan BD
    Transpl Immunol; 1997 Sep; 5(3):189-98. PubMed ID: 9402685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-inflammatory effect of the SOCC blocker SK&F 96365 on mouse lymphocytes after stimulation by Con A or PMA/ionomycin.
    Ye Y; Zhang Y; Lu X; Huang X; Zeng X; Lai X; Zeng Y
    Immunobiology; 2011 Sep; 216(9):1044-53. PubMed ID: 21470712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of Brequinar as an immunosuppressive drug for transplantation.
    Makowka L; Sher LS; Cramer DV
    Immunol Rev; 1993 Dec; 136():51-70. PubMed ID: 8132203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevention of accelerated cardiac allograft rejection in sensitized recipients after treatment with brequinar sodium.
    Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L
    Transplantation; 1993 Oct; 56(4):898-904. PubMed ID: 8212214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric analysis of the molecular mechanisms of immunosuppressive action of the active metabolite of leflunomide and its malononitrilamide analogues in a novel whole blood assay.
    Slauson SD; Silva HT; Sherwood SW; Morris RE
    Immunol Lett; 1999 Apr; 67(3):179-83. PubMed ID: 10369124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vomitoxin-mediated IL-2, IL-4, and IL-5 superinduction in murine CD4+ T cells stimulated with phorbol ester calcium ionophore: relation to kinetics of proliferation.
    Ouyang YL; Azcona-Olivera JI; Murtha J; Pestka JJ
    Toxicol Appl Pharmacol; 1996 Jun; 138(2):324-34. PubMed ID: 8658534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of canine distemper virus replication by blocking pyrimidine nucleotide synthesis with A77 1726, the active metabolite of the anti-inflammatory drug leflunomide.
    Li Y; Yi L; Cheng S; Wang Y; Wang J; Sun J; Zhang Q; Xu X
    J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33416466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.